JPMorgan Chase & Co. Lowers Stock Holdings in Amentum Holdings, Inc. (NYSE:AMTM)

JPMorgan Chase & Co. reduced its position in shares of Amentum Holdings, Inc. (NYSE:AMTMFree Report) by 58.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 113,674 shares of the company’s stock after selling 157,295 shares during the period. JPMorgan Chase & Co.’s holdings in Amentum were worth $2,391,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of AMTM. Vanguard Group Inc. boosted its holdings in shares of Amentum by 18.0% during the fourth quarter. Vanguard Group Inc. now owns 16,542,447 shares of the company’s stock worth $347,888,000 after purchasing an additional 2,529,173 shares during the last quarter. Primecap Management Co. CA increased its position in shares of Amentum by 21.7% in the fourth quarter. Primecap Management Co. CA now owns 6,414,379 shares of the company’s stock worth $134,894,000 after acquiring an additional 1,143,097 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its position in Amentum by 469.4% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 1,948,684 shares of the company’s stock valued at $40,981,000 after purchasing an additional 1,606,442 shares during the period. Thrivent Financial for Lutherans boosted its stake in shares of Amentum by 201.0% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,611,796 shares of the company’s stock valued at $33,896,000 after purchasing an additional 1,076,375 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Amentum by 66.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,264,257 shares of the company’s stock worth $26,587,000 after acquiring an additional 503,741 shares during the last quarter. 39.93% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AMTM has been the topic of a number of research analyst reports. The Goldman Sachs Group assumed coverage on shares of Amentum in a research note on Thursday, March 20th. They set a “neutral” rating and a $21.00 price objective on the stock. Royal Bank of Canada reiterated a “sector perform” rating and issued a $24.00 price target on shares of Amentum in a research note on Thursday, February 6th. Morgan Stanley initiated coverage on Amentum in a report on Wednesday, April 16th. They issued an “underweight” rating and a $19.00 price objective for the company. BTIG Research began coverage on Amentum in a report on Tuesday, April 15th. They issued a “buy” rating and a $30.00 price target for the company. Finally, Truist Financial reduced their price objective on Amentum from $31.00 to $24.00 and set a “buy” rating on the stock in a research note on Monday, April 14th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Amentum has an average rating of “Hold” and a consensus target price of $24.71.

Check Out Our Latest Stock Report on Amentum

Insider Buying and Selling

In other Amentum news, Director Barbara Loughran acquired 4,600 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was purchased at an average price of $21.23 per share, for a total transaction of $97,658.00. Following the transaction, the director now owns 4,600 shares in the company, valued at $97,658. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Steven J. Demetriou acquired 100,000 shares of the firm’s stock in a transaction on Wednesday, February 12th. The shares were bought at an average cost of $20.81 per share, for a total transaction of $2,081,000.00. Following the acquisition, the insider now owns 620,893 shares in the company, valued at approximately $12,920,783.33. The trade was a 19.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 18.67% of the stock is owned by company insiders.

Amentum Stock Performance

NYSE AMTM opened at $19.77 on Thursday. Amentum Holdings, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $34.47. The company’s 50-day moving average is $18.72. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.59 and a current ratio of 1.59.

Amentum (NYSE:AMTMGet Free Report) last released its earnings results on Tuesday, February 4th. The company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.06. On average, equities research analysts expect that Amentum Holdings, Inc. will post 2.1 EPS for the current fiscal year.

Amentum Company Profile

(Free Report)

Amentum Holdings, Inc provides engineering and technology solutions to address challenges in science, security, and sustainability. It serves various markets, such as energy and environment, space, intelligence, defense, civilian, commercial, and international markets. The company was incorporated in 2010 and is headquatered in Chantilly, Virginia.

See Also

Want to see what other hedge funds are holding AMTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amentum Holdings, Inc. (NYSE:AMTMFree Report).

Institutional Ownership by Quarter for Amentum (NYSE:AMTM)

Receive News & Ratings for Amentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amentum and related companies with MarketBeat.com's FREE daily email newsletter.